Kano Therapeutics Inc
Kano Therapeutics Inc, based in Cambridge, MA, is pioneering advancements in cell therapy through its innovative TFome platform, which leverages cutting-edge technologies in synthetic biology, gene editing, and machine learning. This groundbreaking approach enables the production of induced pluripotent stem cell (iPSC) therapies at a significantly accelerated pace, enhancing efficiency, quality, and accessibility for patients across various therapeutic areas.
With a dedicated team of visionary scientists and operators, Kano Therapeutics is focused on developing best-in-class cell therapy programs targeting gastrointestinal, neurological, and immunological diseases. Their commitment to pushing scientific boundaries aims to deliver transformative treatments that can significantly improve patient outcomes.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

